*3.5. Short-Term Outcome*

Of the 586 included neonates, 26 (4.4%) suffered from proven early or late bacterial infection/sepsis and one neonate (0.2%) suffered from NEC. Thirteen neonates (2.2%) were diagnosed with IVH grade one and two neonates (0.3%) with IVH grade three. Five neonates (0.9%) developed PVL. Three patients (0.5%) died during the neonatal period. There was no difference in body temperature between neonates with one of the abovementioned adverse outcomes neither when testing for the combined endpoint (*p* = 0.238) nor for individual testing.
